Quick Answer
Phio Pharmaceuticals Corp. reported Stockholders Equity of $20.15 million for fiscal year 2025.
Phio Pharmaceuticals Corp. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $20.15M | +326.6% |
| 2024 | $4.72M | -38.9% |
| 2023 | $7.73M | -28.7% |
| 2022 | $10.84M | -50.6% |
| 2021 | $21.93M | +68.5% |
| 2020 | $13.02M | +126.5% |
| 2019 | $5.75M | -57.7% |
| 2018 | $13.58M | +640.8% |
| 2017 | $1.83M | -83.1% |
| 2016 | $10.86M | +22.1% |
| 2015 | $8.89M | +223.9% |
| 2014 | $2.75M | -44.5% |
| 2013 | $4.94M | +184.6% |
| 2012 | -$5.84M | -894.9% |
| 2011 | -$587.0K | -124.2% |
| 2010 | $2.43M | +227.9% |
| 2009 | $741.0K | -91.7% |
| 2008 | $8.97M | -17.1% |
| 2007 | $10.82M | +541050.0% |
| 2006 | $2.0K | +100.4% |
| 2005 | -$450.0K | +53.5% |
| 2004 | -$968.0K | -987.6% |
| 2003 | -$89.0K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.84M | +98.9% | -2.5% |
| June 30, 2025 | $10.10M | +167.6% | -17.1% |
| March 31, 2025 | $12.17M | +117.2% | +157.7% |
| December 31, 2024 | $4.72M | -38.9% | -4.5% |
| September 30, 2024 | $4.95M | -31.4% | +31.1% |
| June 30, 2024 | $3.77M | -61.9% | -32.7% |
| March 31, 2024 | $5.60M | -23.3% | -27.5% |
| December 31, 2023 | $7.73M | -28.7% | +7.2% |
- Phio Pharmaceuticals Corp. showed an increase of +326.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2003–2025 period, Phio Pharmaceuticals Corp.’s stockholders equity has grown by 22737.1% (from -$89.0 thousand to $20.15 million).
- The most recent figure is from Phio Pharmaceuticals Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: